Biochem Biophys Res Commun

1. ZHU J, Tang W, Wu X, Mu M, et al
   Tectorigenin improves metabolic dysfunction-associated steatohepatitis by down-regulating tRF-3040b and promoting mitophagy to inhibit pyroptosis pathway.
   Biochem Biophys Res Commun. 2024;720:150118.
   

   >> Share

   
   

   
   BMC Cancer

2. CHEN KA, Huang WM, Chen EY, Ho PK, et al
   Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan.
   BMC Cancer. 2024;24:622.
   

   >> Share

   
   
3. ZHANG H, Huang G, Li Q, Wang Y, et al
   Construction and validation of a novel tumor morphology immune inflammatory nutritional score (TIIN score) for intrahepatic cholangiocarcinoma: a multicenter study.
   BMC Cancer. 2024;24:630.
   

   >> Share

   
   
4. LIU S, Wei Y, Nie L, Tang Z, et al
   Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma.
   BMC Cancer. 2024;24:614.
   

   >> Share

   
   
5. WAN B, Cheng M, He T, Zhang L, et al
   UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/beta-catenin pathway.
   BMC Cancer. 2024;24:618.
   

   >> Share

   
   
6. MA M, Xie K, Jin T, Xu F, et al
   Predictive nomograms based on gamma-glutamyl transpeptidase to prealbumin ratio for prognosis of hepatocellular carcinoma patients without microvascular invasion.
   BMC Cancer. 2024;24:617.
   

   >> Share

   
   
7. HUANG K, Qian T, Chen W, Lao M, et al
   The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.
   BMC Cancer. 2024;24:620.
   

   >> Share

   
   
8. DU Y, Xu Y, Guo X, Tan C, et al
   Methylation-regulated tumor suppressor gene PDE7B promotes HCC invasion and metastasis through the PI3K/AKT signaling pathway.
   BMC Cancer. 2024;24:624.
   

   >> Share

   
   

   
   BMC Gastroenterol

9. XIANG D, Fu L, Yang Y, Liu C, et al
   Evaluating the diagnostic accuracy of heat shock proteins and their combination with Alpha-Fetoprotein in the detection of hepatocellular carcinoma: a meta-analysis.
   BMC Gastroenterol. 2024;24:178.
   

   >> Share

   
   
10. LIU Z, Ren Q, Mu H, Zeng Y, et al
    Preliminary study on the diagnostic value of LEAP-2 and CK18 in biopsy-proven MAFLD.
    BMC Gastroenterol. 2024;24:182.
    

    >> Share

    
    

    
    Cancer

11. NING T, Li D, Deng T, Bai Y, et al
    Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study.
    Cancer. 2024 May 23. doi: 10.1002/cncr.35377.
    

    >> Share

    
    

    
    Dig Dis Sci

12. KOCH DG, Rockey DC, Litwin SS, Tedford RJ, et al
    H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure.
    Dig Dis Sci. 2024 May 23. doi: 10.1007/s10620-024-08438.
    

    >> Share

    
    

    
    Eur Radiol

13. GU K, Min JH, Lee JH, Shin J, et al
    Prognostic significance of MRI features in patients with solitary large hepatocellular carcinoma following surgical resection.
    Eur Radiol. 2024 May 20. doi: 10.1007/s00330-024-10780.
    

    >> Share

    
    
14. CHEN J, Wu Z, Zhang Z, Chen Y, et al
    Apparent diffusion coefficient and tissue stiffness are associated with different tumor microenvironment features of hepatocellular carcinoma.
    Eur Radiol. 2024 May 20. doi: 10.1007/s00330-024-10743.
    

    >> Share

    
    

    
    Gastroenterology

15. LEE BP, Louvet A
    Longitudinal Change of Alcohol Use is a Dynamic Contributor to Steatotic Liver Disease Progression.
    Gastroenterology. 2024;166:965-967.
    

    >> Share

    
    
16. LO GH
    The Optimal Duration of Vasoconstrictors for Acute Variceal Hemorrhage: Longer Is Safer?
    Gastroenterology. 2024;166:1197-1198.
    

    >> Share

    
    
17. WANG H, Yuan S, Zheng Q, Zhang S, et al
    Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs.
    Gastroenterology. 2024;166:1130-1144.
    

    >> Share

    
    

    
    Gastrointest Endosc

18. GANGASANI N, Tang Z, Agrawal D
    Modifying the Sengstaken-Blakemore tube to treat variceal bleeding.
    Gastrointest Endosc. 2024;99:1056-1057.
    

    >> Share

    
    
19. DIEHL DL, Sangwan V, Johal AS, Khara HS, et al
    Comparing a 19-gauge fine-needle biopsy needle with a 22-gauge fine-needle biopsy needle for EUS-guided liver biopsy sampling: a prospective randomized study.
    Gastrointest Endosc. 2024;99:931-937.
    

    >> Share

    
    

    
    Gut

20. BABUTA M, Morel C, de Carvalho Ribeiro M, Calenda C, et al
    Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis.
    Gut. 2024 May 22:gutjnl-2023-331447. doi: 10.1136/gutjnl-2023-331447.
    

    >> Share

    
    

    
    Hepatology

21. MOORE MP, Wang X, Kennelly JP, Shi H, et al
    Low MBOAT7 expression, a genetic risk for MASH, promotes a pro-fibrotic pathway involving hepatocyte TAZ upregulation.
    Hepatology. 2024 May 22. doi: 10.1097/HEP.0000000000000933.
    

    >> Share

    
    

    
    Indian J Gastroenterol

22. PAI G, Achutha D
    Hepatomegaly and hyperlipidemia in a toddler.
    Indian J Gastroenterol. 2024 May 23. doi: 10.1007/s12664-024-01609.
    

    >> Share

    
    

    
    Int J Cancer

23. PUPACDI B, Loffredo CA, Budhu A, Rabibhadana S, et al
    The landscape of etiological patterns of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in Thailand.
    Int J Cancer. 2024 May 18. doi: 10.1002/ijc.35034.
    

    >> Share

    
    

    
    J Hepatol

24. DI COLA S, D'Amico G, Caraceni P, Schepis F, et al
    Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis.
    J Hepatol. 2024 May 21:S0168-8278(24)00355-6. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
25. CHAPUS F, Giraud G, Huchon P, Roda M, et al
    Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytes.
    J Hepatol. 2024 May 21:S0168-8278(24)00351-9. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
26. CHEN J, Kaya NA, Zhang Y, Kendarsari RI, et al
    A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and 'bad apple' effect on clinical trajectory.
    J Hepatol. 2024 May 21:S0168-8278(24)00352-0. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
27. COLAPIETRO F, Lleo A
    Reply: Incidence And Predictors Of Hepatocellular Carcinoma In Patients With Autoimmune Hepatitis?
    J Hepatol. 2024 May 20:S0168-8278(24)00354-4. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
28. 
    Erratum to "EASL Clinical Practice Guidelines on acute-on-chronic liver failure" [J Hepatol 79 (2023) 461-491].
    J Hepatol. 2024 May 20:S0168-8278(24)00164-8. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
29. FRANCQUE S, Krag A, Shawcross DL, Zelber-Sagi S, et al
    A Turning point in Hepatology? EASL Reflects on the First Approved Drug for MASH.
    J Hepatol. 2024 May 16:S0168-8278(24)00340-4. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    

    
    Lancet

30. DE OLIVEIRA FRANCO A, Uberti Dos Santos V, von Ameln Lovison O, Zavascki AP, et al
    Invasive liver abscess syndrome with central nervous system involvement caused by hypermucoviscous Klebsiella pneumoniae: positive string test.
    Lancet. 2024;403:2257-2258.
    

    >> Share

    
    

    
    PLoS One

31. BAN JY, Kang TW, Jeong WK, Lee MW, et al
    Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.
    PLoS One. 2024;19:e0304352.
    

    >> Share

    
    
32. CHU YH, Pang BY, Yang M, Meng Q, et al
    The intervention of curcumin on rodent models of hepatic fibrosis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0304176.
    

    >> Share

    
    
33. TARU MG, Tefas C, Neamti L, Minciuna I, et al
    FAST and Agile-the MASLD drift: Validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria of prevalent caucasian origin.
    PLoS One. 2024;19:e0303971.
    

    >> Share

    
    
34. POSCHEL T, Blank V, Schlosser T, Lingscheidt T, et al
    Ultrasound-guided percutaneous biopsy for focal liver lesions: Adverse events and diagnostic yield in a single-centre analysis.
    PLoS One. 2024;19:e0304026.
    

    >> Share

    
    
35. SHEN Y, Fan J, Liu S, Tao L, et al
    Exploring pathogenesis and biomarkers through establishment of a rat model of male infertility with liver depression and kidney deficiency.
    PLoS One. 2024;19:e0303189.
    

    >> Share

    
    
36. WEN C, Zhang X, Li Y, Xiao W, et al
    An interpretable machine learning model for predicting 28-day mortality in patients with sepsis-associated liver injury.
    PLoS One. 2024;19:e0303469.
    

    >> Share

    
    
37. MORENO J, Gluud LL, Galsgaard ED, Hvid H, et al
    Identification of ligand and receptor interactions in CKD and MASH through the integration of single cell and spatial transcriptomics.
    PLoS One. 2024;19:e0302853.
    

    >> Share

    
    
38. DONG X, Deng Y, Chen G
    Selenium intake in relation to all-cause and cardiovascular mortality in individuals with nonalcoholic fatty liver disease: A nationwide study in nutrition.
    PLoS One. 2024;19:e0303140.
    

    >> Share

    
    

    
    Semin Liver Dis

39. BALOGUN O, Nejak-Bowen K
    Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs.
    Semin Liver Dis. 2024 May 17. doi: 10.1055/s-0044-1787076.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share